Novartis AG

(NYSE:NVS)

Latest On Novartis AG (NVS):

Date/Time Type Description Signal Details
2024-03-07 04:57 ESTDividendA dividend of $3.78 has been announced on Feb 12, 2024. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 7, 2024.Neutral
2023-05-27 22:22 ESTNewsWhy 2023 is turning into the year of the healthcare spinoffN/A
2023-05-26 18:42 ESTNewsEMA recommends revoking approval of Novartis' sickle cell disease drug Adakveo in EUN/A
2023-05-25 14:01 ESTNewsNovartis' Sandoz gets EMA review for biosimilar to Amgen's Prolia, XgevaN/A
2023-05-22 14:42 ESTNewsAvrobio up 69% on plans to sell gene therapy program to NovartisN/A
2023-05-15 16:58 ESTNewsNovartis appoints 10-member board for Sandoz unit ahead of spinoffN/A
2023-05-10 09:08 ESTNewsNovartis' Sandoz to use Evotec's technology in pact to develop biosimilarsN/A
2023-05-04 05:49 ESTNewsNovartis' Sandoz inks pact to exclusively sell 6 products in USN/A
2023-05-03 17:23 ESTNewsImmix stock slumps ~20% amid interim data for IMX-110 in colorectal cancerN/A
2023-04-27 12:03 ESTNewsNovartis Cosentyx gets EMA panel backing to treat painful skin disorderN/A
2023-04-26 23:42 ESTNewsNovartis: Valuation Seems FairN/A
2023-04-26 11:33 ESTNewsBristol Myers to acquire viral vector manufacturing site in Illinois from NovartisN/A
2023-04-26 11:33 ESTNewsNovartis' iptacopan improves hemoglobin levels in rare blood disorder trial full dataN/A
2023-04-25 23:21 ESTNewsHot Stocks: Earnings sparked movement in PEP, JBLU, NVS, MCD, BIIB and HALN/A
2023-04-25 11:18 ESTNewsNovartis beats Q1 top and bottom line estimates; raises FY23 outlook & planned spin-off on track for H2N/A
2023-04-25 11:18 ESTNewsNovartis trades higher as Entresto, new drugs drive Q1 revenue, raises FY23 outlookN/A
2023-04-25 11:18 ESTNewsNovartis AG 2023 Q1 - Results - Earnings Call PresentationN/A
2023-04-25 11:18 ESTNewsNovartis: Limited Upside Despite Strong First Quarter Results, Improved GuidanceN/A
2023-04-25 11:17 ESTNewsNovartis AG (NVS) Q1 2023 Earnings Call TranscriptN/A
2023-04-24 23:47 ESTNewsNovartis hits 52-week high as Wall Street awaits Q1 2023 earningsN/A
2023-04-20 15:27 ESTNewsNovartis Kesimpta shows benefit in multiple sclerosis patients in 5-year dataN/A
2023-04-20 15:26 ESTNewsNovartis, BeiGene tislelizumab meets main goal in gastric/esophagus cancer trialN/A
2023-04-19 16:50 ESTNewsAmgen wins appeals court ruling in patent dispute over psoriasis drug OtezlaN/A
2023-04-04 05:38 ESTNewsNovartis Humira biosimilar's high concentration gets approval in EUN/A
2023-03-31 12:40 ESTNewsNovartis' heart drug Entresto gets EMA nod for expanded use in childrenN/A
2023-03-28 14:10 ESTNewsBicycle stock pops on cancer drug discovery pact with Novartis, gets $50M upfrontN/A
2023-03-27 22:52 ESTNewsHot Stocks: ROKU and PINS rises on analyst upgrade; CAT stock and FYBR falls on downgrade; NVS higher on cancer trial successN/A
2023-03-27 22:52 ESTNewsNovartis upgraded to hold at Deutsche Bank following breast cancer drug resultsN/A
2023-03-27 22:51 ESTNewsWhy did Novartis stock go up today? Early breast cancer trial resultsN/A
2023-03-27 07:22 ESTNewsNovartis stock jumps on cancer trial successN/A
2023-03-22 19:34 ESTNewsNovartis Humira biosimilar's high concentration gets FDA approvalN/A
2023-03-22 19:34 ESTNewsNovartis to not go ahead with UK trial of cholesterol therapy Leqvio - reportN/A
2023-03-18 07:31 ESTNewsSangamo down post-market as Novartis, Biogen end collaborationsN/A
2023-03-17 16:30 ESTNewsNovartis Tafinlar Mekinist combo gets FDA approval to treat brain cancer in childrenN/A
2023-03-14 12:27 ESTNewsNovartis begins sale of certain eye care assets - reportN/A
2023-03-13 05:53 ESTNewsNovartis launches CHF10B stock buyback programN/A
2023-03-10 15:52 ESTNewsNovartis' Sandoz to invest $400M to build biosimilar production plant in SloveniaN/A
2023-03-09 04:56 ESTDividendA dividend of $3.47 has been announced on Feb 2, 2023. It will be paid Mar 20, 2023 with an ex-dividend date of Mar 9, 2023.Neutral
2023-03-06 21:20 ESTNewsVoyager stock pops on getting $25M from Novartis under license dealN/A
2023-03-06 21:19 ESTNewsNovartis: Cautiously Optimistic, HoldN/A
2023-03-03 14:06 ESTNewsNovartis files for FDA approval of radioligand facility to ramp up production of PluvictoN/A
2023-02-25 00:14 ESTNewsNovartis ends NASH collaboration with PliantN/A
2023-02-23 21:35 ESTNewsIntellia, Novartis end gene editing partnership for sickle cell diseaseN/A
2023-02-20 15:29 ESTNewsNovartis appoints perfume company Firmenich CEO as chairman-designate of SandozN/A
2023-02-09 03:55 ESTNewsNovartis CEO to lead top U.S. pharma lobbyN/A
2023-02-08 14:42 ESTNewsNovartis, Bayer commit financial aid to quake hit Turkey, Syria as rescue operations continueN/A
2023-02-07 12:29 ESTNewsNovartis' biosimilar of Amgen's bone disorder drugs Prolia, Xgeva gets FDA reviewN/A
2023-02-03 01:25 ESTNewsNovartis drops plans to develop Huntington’s disease candidateN/A
2023-02-01 23:01 ESTNewsNovartis ends plans to develop Cosentyx for another autoimmune conditionN/A
2023-02-01 10:00 ESTNewsNovartis reports mixed Q4 earnings, continue to grow with further core margin expansion; initiates FY23 guidanceN/A

About Novartis AG (NVS):

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, established, and cardiovascular, renal and metabolism medicine products. The Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and an agreement with CureVac to manufacture COVID-19 vaccine candidate CVnCoV. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

NVS Quotes by TradingView

See Advanced Chart

General

  • Name Novartis AG
  • Symbol NVS
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 105,794
  • Last Split Factor1116:1000
  • Last Split Date2019-04-09
  • Fiscal Year EndDecember
  • IPO Date1991-11-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.novartis.com
View More

Valuation

  • Trailing PE 24.24
  • Forward PE 13.44
  • Price/Sales (Trailing 12 Mt.) 3.9
  • Price/Book (Most Recent Quarter) 3.38
  • Enterprise Value Revenue 4.35
  • Enterprise Value EBITDA 12.6
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $6.37
  • Next Year EPS Estimate $6.79
  • Next Quarter EPS Estimate $1.58
  • Profit Margin 16%
  • Operating Margin 24%
  • Return on Assets 6%
  • Return on Equity 14%
  • Revenue 49.76 billion
  • Earnings Per Share $3.52
  • Revenue Per Share $21.85
  • Gross Profit 35.36 billion
  • Quarterly Earnings Growth 1.9%
View More

Highlights

  • Market Capitalization 192.55 billion
  • EBITDA 17.27 billion
  • PE Ratio 16.37
  • PEG Ratio 2.19
  • Analyst Target Price $104.67
  • Book Value Per Share $25.08
View More

Share Statistics

  • Shares Outstanding 2.26 billion
  • Shares Float 2.11 billion
  • % Held by Insiders <1%
  • % Held by Institutions 10.08%
  • Shares Short 6.7 million
  • Shares Short Prior Month 5.35 million
  • Short Ratio 2.94
View More

Technicals

  • Beta 0.48
  • 52 Week High $94.72
  • 52 Week Low $67.52
  • 50 Day Moving Average 88.18
  • 200 Day Moving Average 88.65
View More

Dividends

  • Forward Annual Dividend Rate $3.2
  • Forward Annual Dividend Yield 3.74%
  • Payout Ratio 58%
  • Dividend Date 2021-03-15
  • ExDividend Date 2021-03-04
  • Dividend Per Share $3.4
  • Dividend Yield 3.09%
View More

Novartis AG (NVS) Dividend Calendar:

Novartis AG pays an annual dividend of $3.2 per share, with a dividend yield of 3.09%.
NVS's last dividend payment was made to shareholders on March 15, 2021.
Novartis AG pays out 58% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2024-03-072024-04-192024-03-082024-02-12$3.74
2023-03-092023-03-202023-03-102023-02-02$3.47
2022-03-082022-03-172022-03-092022-02-03$3.36
2021-03-042021-03-152021-03-052021-01-26$3.38
2020-03-032020-03-122020-03-042020-01-31$3.04
2019-03-042019-03-132019-03-05$2.83
2018-03-062018-04-252018-03-07$2.94
2017-03-012017-04-202017-03-03$2.72
2016-02-242016-04-152016-02-26$2.72
2015-03-022015-04-202015-03-042015-01-30$2.82
2024-03-070000-00-002024-03-082024-02-12$3.78
2016-02-242016-02-26$2.76

Novartis AG (NVS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-01-26$13.03 billion$1.34$1.39-3.81%
2020-09-302020-10-27$12.54 billion$1.52$1.454.88%
2020-06-302020-07-21$11.62 billion$1.36$1.332.07%
2020-03-312020-04-28$12.71 billion$1.56$1.3615.02%
2019-12-312020-01-29$12.72 billion$1.32$1.311.01%
2019-09-302019-10-22$12.48 billion$1.41$1.354.61%
2019-06-302019-07-18$12.02 billion$1.34$1.248.5%
2019-03-312019-04-24$11.46 billion$1.21$1.21-0.17%
2018-12-312019-01-30$13.66 billion$1.25$1.30-3.48%
2018-09-302018-10-18$13.12 billion$1.32$1.34-1.78%
2018-06-302018-07-18$13.45 billion$1.29$1.281.08%
2018-03-312018-04-19$12.69 billion$1.28$1.270.79%
2017-12-312018-01-24$12.92 billion$1.21$1.173.84%
2017-09-302017-10-24$12.41 billion$1.29$1.243.81%
2017-06-302017-07-18$12.24 billion$1.22$1.174.59%
2017-03-312017-04-25$11.54 billion$1.13$1.102.28%
2016-12-312017-01-25$12.32 billion$1.12$1.101.42%
2016-09-302016-10-25$12.13 billion$1.23$1.193.28%
2016-06-302016-07-19$12.47 billion$1.23$1.175.2%
2016-03-312016-04-21$11.6 billion$1.17$1.161.22%
2015-12-312016-01-27$12.52 billion$1.12$1.18-5.45%
2015-09-302015-10-27$12.27 billion$1.27$1.31-3.05%
2015-06-302015-07-21$12.69 billion$1.25$1.240.81%
2015-03-312015-04-23$11.96 billion$1.29$1.1017.27%
2014-12-312015-01-27$13.13 billion$1.21$1.210%
2014-09-302014-10-28$13.05 billion$1.37$1.296.2%
2014-06-302014-07-17$13.41 billion$1.34$1.40-4.29%
2014-03-312014-04-24$12.83 billion$1.28$1.33-3.76%
2013-12-312014-01-29$13.44 billion$1.19$1.26-5.56%
2013-09-302013-10-22$12.75 billion$1.25$1.31-4.58%
2013-06-302013-07-17$13.13 billion$1.28$1.29-0.78%
2013-03-312013-04-24$12.77 billion$1.32$1.283.13%
2012-12-312013-01-23$14.83 billion$1.27$1.196.72%
2012-09-302012-10-25$13.81 billion$1.34$1.36-1.47%
2012-06-302012-07-19$14.3 billion$1.38$1.296.98%
2012-03-312012-04-24$13.74 billion$1.27$1.32-3.79%
2011-12-312012-01-25$14.78 billion$1.23$1.202.5%
2011-09-302011-10-25$14.84 billion$1.45$1.51-3.97%
2011-06-302011-07-19$14.92 billion$1.48$1.405.71%
2011-03-312011-04-19$14.03 billion$1.41$1.317.63%
2010-12-312011-01-27$14.2 billion$1.14$1.25-8.8%
2010-09-302010-10-21$12.58 billion$1.27$1.205.83%
2010-06-302010-07-15$11.72 billion$1.20$1.136.19%
2010-03-312010-04-20$12.13 billion$1.44$1.2317.07%
2009-12-312010-01-26$12.93 billion$1.01$1.10-8.18%
2009-09-302009-10-22$11.09 billion$0.92$0.95-3.16%
2009-06-302009-07-16$10.55 billion$0.89$0.854.71%
2009-03-312009-04-23$9.71 billion$0.87$0.870%
2008-12-312009-01-28$10.08 billion$0.66$0.79-16.46%
2008-09-302008-10-20$10.75 billion$0.92$0.95-3.16%
2008-06-302008-07-17$10.73 billion$0.98$0.935.38%
2008-03-312008-04-21$9.91 billion$1.02$0.8914.61%
2007-12-312008-01-17$9.93 billion$0.40$0.73-45.21%
2007-09-302007-10-18$9.61 billion$0.68$0.76-10.53%
2007-06-302007-07-17$9.4 billion$0.83$0.786.41%
2007-03-312007-04-23$9.13 billion$0.92$0.849.52%
2006-12-312007-01-18$9.4 billion$0.70$0.78-10.26%
2006-09-302006-10-19$8.82 billion$0.79$0.763.95%
2006-06-302006-07-17$8.51 billion$0.73$0.79-7.59%
2006-03-312006-04-24$7.67 billion$0.83$0.7116.9%
2005-12-312006-01-19$7.45 billion$0.58$0.71-18.31%
2005-09-302005-10-18$8.42 billion$0.71$0.72-1.39%
2005-06-302005-07-14$7.8 billion$0.70$0.666.06%
2005-03-312005-04-21$7.34 billion$0.64
2004-12-312005-01-20$7.58 billion$0.56$0.60-6.67%
2004-09-302004-10-21$7.06 billion$0.63$0.588.62%
2004-06-302004-07-20$6.97 billion$0.63$0.596.78%
2004-03-312004-04-22$6.64 billion$0.52$0.53-1.89%
2003-12-312004-01-22$6.73 billion$0.55$0.533.77%
2003-09-302003-10-20$6.21 billion$0.52$0.520%
2003-06-302003-07-21$6.2 billion$0.52$0.511.96%
2003-03-312003-04-15$5.72 billion$0.43$0.46-6.52%
2002-12-312003-01-23$7 billion$0.46$0.51-9.86%
2002-09-302002-10-17$5.54 billion$0.47$0.447.11%
2002-06-302002-06-30$6.16 billion$0.50
2002-03-312002-03-31$4.74 billion$0.41
1997-06-301997-09-02$0.79$0.790%
1997-03-311997-04-22$0.52$0.4515.56%

Novartis AG (NVS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Novartis AG (NVS) Chart:

Novartis AG (NVS) News:

Below you will find a list of latest news for Novartis AG (NVS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Novartis AG (NVS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-16600CALL0 0303.17TRUE00
2025-05-16650CALL0 0267.03TRUE00
2025-05-16700CALL0 0225.63TRUE00
2025-05-16750CALL0 0194.83TRUE00
2025-05-16800CALL0 0165.66TRUE00
2025-05-16850CALL0 0115.01TRUE00
2025-05-169011CALL0 1599.73TRUE00
2025-05-16959.2CALL0 34469.09TRUE00
2025-05-161007.79CALL5 527130.31TRUE7.790
2025-05-161054.28CALL3 55836.67TRUE-0.55-0.11
2025-05-161100.8CALL1328 228027.92FALSE-0.35-0.3
2025-05-161150.07CALL33 189031.03FALSE-0.08-0.53
2025-05-161200.04CALL16 102345.21FALSE0.040
2025-05-161250.1CALL0 2557.09FALSE00
2025-05-161300.05CALL0 20110.5FALSE00
2025-05-161350CALL0 0118.15FALSE00
2025-05-161400.1CALL0 1144.52FALSE00
2025-05-161450CALL0 0159.98FALSE00
2025-05-161500CALL0 0174.61FALSE00
2025-05-161550CALL0 0188.5FALSE00
2025-05-161600CALL0 0201.73FALSE00
2025-05-161650CALL0 0214.37FALSE00
2025-05-16600PUT0 0315.81FALSE00
2025-05-16650PUT0 0308.1FALSE00
2025-05-16700PUT0 0272.74FALSE00
2025-05-16750PUT0 0237.08FALSE00
2025-05-16800.8PUT0 4136.93FALSE00
2025-05-16850.24PUT0 2132.86FALSE00
2025-05-16900.05PUT0 3590.09FALSE00
2025-05-16950.11PUT3 33872.42FALSE0.110
2025-05-161000.1PUT41 59548.29FALSE-0.01-0.09
2025-05-161050.37PUT48 270436.43FALSE-0.23-0.38
2025-05-161101.85PUT105 113626.65TRUE-0.25-0.12
2025-05-161154.69PUT0 37883.81TRUE00
2025-05-161205.9PUT0 071.84TRUE00
2025-05-161250PUT0 092.99TRUE00
2025-05-161300PUT0 0109.06TRUE00
2025-05-161350PUT0 0182.41TRUE00
2025-05-161400PUT0 0106.53TRUE00
2025-05-161450PUT0 0244.37TRUE00
2025-05-161500PUT0 0262.96TRUE00
2025-05-161550PUT0 0280.53TRUE00
2025-05-161600PUT0 0297.19TRUE00
2025-05-161650PUT0 0313.04TRUE00
2025-06-20550CALL0 0119.21TRUE00
2025-06-20600CALL0 0115.07TRUE00
2025-06-20650CALL0 097.73TRUE00
2025-06-20700CALL0 092.2TRUE00
2025-06-20750CALL0 078.79TRUE00
2025-06-20800CALL0 066.24TRUE00
2025-06-20850CALL0 058.84TRUE00
2025-06-20900CALL0 053.75TRUE00
2025-06-20950CALL0 041.19TRUE00
2025-06-2010014.2CALL0 6132.76TRUE00
2025-06-201055.3CALL1 3523.37TRUE-1.14-0.18
2025-06-201102.27CALL13 17320.9FALSE-0.58-0.2
2025-06-201150.9CALL8 123021.65FALSE-0.28-0.24
2025-06-201200.25CALL18 112221.17FALSE-0.1-0.29
2025-06-201250.13CALL10 23524.14FALSE0.130
2025-06-201300.2CALL0 826.93FALSE00
2025-06-201350.1CALL0 131.55FALSE00
2025-06-201400CALL0 049.3FALSE00
2025-06-201450CALL0 058.65FALSE00
2025-06-201500CALL0 063.69FALSE00
2025-06-201550CALL0 061.03FALSE00
2025-06-201600CALL0 065.26FALSE00
2025-06-201650CALL0 069.3FALSE00
2025-06-20550PUT0 0113.56FALSE00
2025-06-20600PUT0 093.79FALSE00
2025-06-20650PUT0 068.93FALSE00
2025-06-20700PUT0 059.88FALSE00
2025-06-20750PUT0 053.53FALSE00
2025-06-20800.15PUT0 1045.21FALSE00
2025-06-20850.2PUT0 1238.65FALSE00
2025-06-20900.25PUT1 1135.13FALSE0.151.5
2025-06-20950.32PUT0 21027.81FALSE00
2025-06-201000.73PUT8 30623.47FALSE-0.07-0.09
2025-06-201051.35PUT78 43019.6FALSE-0.39-0.22
2025-06-201103.1PUT51 275015.62TRUE-0.17-0.05
2025-06-201158.14PUT1 52317.9TRUE8.140
2025-06-2012010.62PUT0 31837.2TRUE00
2025-06-201250PUT0 045.77TRUE00
2025-06-201300PUT0 054.69TRUE00
2025-06-201350PUT0 061.97TRUE00
2025-06-201400PUT0 068.78TRUE00
2025-06-201450PUT0 075.19TRUE00
2025-06-201500PUT0 081.25TRUE00
2025-06-201550PUT0 087.01TRUE00
2025-06-201600PUT0 092.49TRUE00
2025-06-201650PUT0 097.72TRUE00
2025-07-18550CALL0 0106.44TRUE00
2025-07-18600CALL0 098.45TRUE00
2025-07-18650CALL0 087.18TRUE00
2025-07-187038.65CALL2 2107.13TRUE38.650
2025-07-18750CALL0 070.94TRUE00
2025-07-18800CALL0 061.88TRUE00
2025-07-188520.5CALL0 053.67TRUE00
2025-07-18900CALL0 043.9TRUE00
2025-07-189517.6CALL0 038.41TRUE00
2025-07-1810015.08CALL0 87031.34TRUE00
2025-07-1810511.2CALL0 173928.16TRUE00
2025-07-181103.4CALL5 82822.97FALSE-1.15-0.25
2025-07-181151.56CALL2 150821.69FALSE-0.54-0.26
2025-07-181200.85CALL14 130223.22FALSE-0.15-0.15
2025-07-181250.33CALL3 41222.67FALSE0.330
2025-07-181300.2CALL4 41624.62FALSE0.010.05
2025-07-181350.25CALL0 25525.47FALSE00
2025-07-181400.25CALL0 14832.93FALSE00
2025-07-181450.2CALL0 32730.86FALSE00
2025-07-181500CALL0 033.84FALSE00
2025-07-181550.15CALL0 5246.96FALSE00
2025-07-18550.15PUT0 1093.56FALSE00
2025-07-18600PUT0 059.72FALSE00
2025-07-18650.05PUT0 354.39FALSE00
2025-07-18700.78PUT0 947.24FALSE00
2025-07-18751.07PUT0 41341.91FALSE00
2025-07-18800.2PUT0 14737.41FALSE00
2025-07-18850.3PUT2 30834.26FALSE0.30
2025-07-18900.65PUT0 69235.99FALSE00
2025-07-18950.73PUT1 149526.43FALSE0.730
2025-07-181001.1PUT0 60120.93FALSE00
2025-07-181052.35PUT469 98520.22FALSE2.350
2025-07-181105.1PUT10 165121.84TRUE5.10
2025-07-181154.9PUT0 104612.08TRUE00
2025-07-181209.4PUT0 20527.91TRUE00
2025-07-1812513.01PUT0 25033.62TRUE00
2025-07-1813023.9PUT0 039.57TRUE00
2025-07-1813528.2PUT0 043.16TRUE00
2025-07-1814033.4PUT0 048.3TRUE00
2025-07-181450PUT0 055.3TRUE00
2025-07-1815043.07PUT0 057.83TRUE00
2025-07-1815548.32PUT0 064.5TRUE00
2025-10-17550CALL0 090.79TRUE00
2025-10-17600CALL0 082.19TRUE00
2025-10-17650CALL0 075.08TRUE00
2025-10-17700CALL0 068.62TRUE00
2025-10-17750CALL0 061.18TRUE00
2025-10-17800CALL0 055.02TRUE00
2025-10-17850CALL0 048.27TRUE00
2025-10-17900CALL0 042.35TRUE00
2025-10-179522.2CALL0 1536.71TRUE00
2025-10-1710016.7CALL0 31132.32TRUE00
2025-10-1710512.7CALL0 28729.55TRUE00
2025-10-171106CALL10 15326.11FALSE-1-0.14
2025-10-171154.1CALL3 28725.67FALSE-0.54-0.12
2025-10-171202.4CALL1 46423.99FALSE2.40
2025-10-171251.35CALL4 47522.99FALSE-0.5-0.27
2025-10-171300.85CALL7 90223.28FALSE0.850
2025-10-171350.66CALL0 45023.52FALSE00
2025-10-171400.65CALL0 17028.43FALSE00
2025-10-171450.45CALL0 1130.63FALSE00
2025-10-171500.3CALL0 8525.08FALSE00
2025-10-171550CALL0 026.35FALSE00
2025-10-171600.25CALL0 1027.36FALSE00
2025-10-17550PUT0 046.63FALSE00
2025-10-17600PUT0 053.81FALSE00
2025-10-17650.15PUT0 37248.98FALSE00
2025-10-17700.46PUT0 143.5FALSE00
2025-10-17751PUT0 137.92FALSE00
2025-10-17800.4PUT0 132.83FALSE00
2025-10-17852.08PUT0 1827.82FALSE00
2025-10-17900.81PUT0 41721.67FALSE00
2025-10-17951.45PUT87 8020.61FALSE-0.05-0.03
2025-10-171002.2PUT4 24318.03FALSE2.20
2025-10-171053PUT0 37317.24FALSE00
2025-10-171106PUT434 49615.05TRUE60
2025-10-171156.8PUT0 5997.79TRUE00
2025-10-1712013.53PUT0 5499.33TRUE00
2025-10-1712513.3PUT0 42016.18TRUE00
2025-10-1713021.8PUT3 20719.07TRUE21.80
2025-10-1713528.8PUT0 022.9TRUE00
2025-10-1714033.72PUT0 026.59TRUE00
2025-10-1714538.53PUT0 030.15TRUE00
2025-10-1715043.44PUT0 033.59TRUE00
2025-10-1715548.44PUT0 036.91TRUE00
2025-10-1716053.39PUT0 040.1TRUE00
2026-01-1647.564CALL0 096.03TRUE00
2026-01-165054.4CALL0 091.88TRUE00
2026-01-16550CALL0 084.06TRUE00
2026-01-166048CALL0 076.78TRUE00
2026-01-16650CALL0 069.92TRUE00
2026-01-167035.4CALL0 1563.68TRUE00
2026-01-167525.89CALL0 157.95TRUE00
2026-01-168026CALL0 1952.58TRUE00
2026-01-168519.68CALL0 5747.21TRUE00
2026-01-1687.528CALL0 7045.19TRUE00
2026-01-169026.06CALL0 37642.53TRUE00
2026-01-1692.517.7CALL0 41040.56TRUE00
2026-01-169521.6CALL0 12538.84TRUE00
2026-01-1697.521CALL0 54737.32TRUE00
2026-01-1610015.8CALL0 125837.7TRUE00
2026-01-1610510.71CALL5 25829.64TRUE10.710
2026-01-161108.56CALL13 172429.76FALSE8.560
2026-01-161155.75CALL5 34929.9FALSE5.750
2026-01-161204.05CALL5 69625.82FALSE4.050
2026-01-161253.13CALL0 48226.98FALSE00
2026-01-161301.95CALL1 29024.9FALSE1.950
2026-01-161351.94CALL0 59523.22FALSE00
2026-01-161401CALL0 36621.64FALSE00
2026-01-161450.96CALL0 5728.17FALSE00
2026-01-161500.65CALL0 11224.56FALSE00
2026-01-161551.4CALL0 024.75FALSE00
2026-01-161600.3CALL0 731.08FALSE00
2026-01-161650.2CALL0 43026.2FALSE00
2026-01-161700.55CALL0 39027.09FALSE00
2026-01-161750.4CALL0 3727.83FALSE00
2026-01-1647.50.18PUT0 3044.11FALSE00
2026-01-16500PUT0 042.59FALSE00
2026-01-16550.22PUT0 20538.51FALSE00
2026-01-16600.48PUT0 134.59FALSE00
2026-01-16650.35PUT0 5732.4FALSE00
2026-01-16701.55PUT0 14230.05FALSE00
2026-01-16750.52PUT0 24231.72FALSE00
2026-01-16800.75PUT0 115825.63FALSE00
2026-01-16851.05PUT2 63622.57FALSE1.050
2026-01-1687.51.1PUT0 64522.99FALSE00
2026-01-16901.35PUT0 69421.56FALSE00
2026-01-1692.52.25PUT0 58521.16FALSE00
2026-01-16951.8PUT0 82120.1FALSE00
2026-01-1697.53.2PUT0 37818.43FALSE00
2026-01-161002.95PUT0 69118.01FALSE00
2026-01-161053.7PUT0 59816.21FALSE00
2026-01-161105.2PUT0 65413.63TRUE00
2026-01-161158.1PUT0 111113.56TRUE00
2026-01-1612010PUT0 3920TRUE00
2026-01-1612515.5PUT0 1970TRUE00
2026-01-1613020.3PUT0 750TRUE00
2026-01-1613522.68PUT0 00TRUE00
2026-01-1614030.4PUT0 00TRUE00
2026-01-161450PUT0 00TRUE00
2026-01-1615043.2PUT0 00TRUE00
2026-01-161550PUT0 019.24TRUE00
2026-01-161600PUT0 024.68TRUE00
2026-01-161650PUT0 028.5TRUE00
2026-01-1617063.2PUT0 031.79TRUE00
2026-01-161750PUT0 034.76TRUE00
2027-01-15500CALL0 073.04TRUE00
2027-01-15550CALL0 068.27TRUE00
2027-01-156038.1CALL0 061.37TRUE00
2027-01-156547.1CALL0 157.01TRUE00
2027-01-157034.3CALL0 1152.8TRUE00
2027-01-15750CALL0 048.68TRUE00
2027-01-158027.9CALL0 546.07TRUE00
2027-01-15850CALL0 043.13TRUE00
2027-01-159026.5CALL1 1641.27TRUE26.50
2027-01-159520.91CALL0 1737.99TRUE00
2027-01-1510020.79CALL0 13036.59TRUE00
2027-01-1510519.6CALL0 2834.78TRUE00
2027-01-1511015.2CALL0 23532.4FALSE00
2027-01-1511512CALL0 24130.98FALSE00
2027-01-1512012CALL0 4429.9FALSE00
2027-01-151257.8CALL0 2729.41FALSE00
2027-01-151304.23CALL0 5328.36FALSE00
2027-01-151355.49CALL0 6226.8FALSE00
2027-01-151404.7CALL0 226.19FALSE00
2027-01-151453.45CALL0 826FALSE00
2027-01-151503.21CALL0 4425.27FALSE00
2027-01-151550CALL0 026.3FALSE00
2027-01-151602.05CALL0 625.22FALSE00
2027-01-151651.55CALL0 728.48FALSE00
2027-01-151701.35CALL0 3028.22FALSE00
2027-01-15500PUT0 030.35FALSE00
2027-01-15550PUT0 027.28FALSE00
2027-01-15601PUT0 1228.67FALSE00
2027-01-15650.7PUT0 932.89FALSE00
2027-01-15700.95PUT0 13023FALSE00
2027-01-15751.75PUT0 16922.33FALSE00
2027-01-15802.12PUT0 37819.1FALSE00
2027-01-15852.54PUT0 6518.97FALSE00
2027-01-15908.02PUT0 44816.73FALSE00
2027-01-15955.4PUT4 23116.03FALSE5.40
2027-01-151006.05PUT0 71413.55FALSE00
2027-01-151058.77PUT2 29712.55FALSE8.770
2027-01-151109.41PUT0 4238.69TRUE00
2027-01-1511511PUT0 28911.95TRUE00
2027-01-1512014.16PUT0 2040TRUE00
2027-01-1512518.34PUT0 1500TRUE00
2027-01-1513028.71PUT0 1120TRUE00
2027-01-1513523.5PUT0 650TRUE00
2027-01-151400PUT0 00TRUE00
2027-01-151450PUT0 00TRUE00
2027-01-151500PUT0 00TRUE00
2027-01-151550PUT0 00TRUE00
2027-01-151600PUT0 00TRUE00
2027-01-151650PUT0 00TRUE00
2027-01-151700PUT0 00TRUE00

Latest NVS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST2$82.55
Jun 13, 2022 7:59 PM EST14$82.55
Jun 13, 2022 7:59 PM EST8$82.53
Jun 13, 2022 7:59 PM EST200$82.54

Novartis AG (NVS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-11-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319026793/0000899243-19-026793-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000089924320017188/0000899243-20-017188-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2019-12-05SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000104746919006660/0001047469-19-006660-index.htm
2020-01-30F-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000609/0001047469-20-000609-index.htm
2020-02-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000795/0001047469-20-000795-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1114448/000104746920000837/0001047469-20-000837-index.htm
2020-02-14POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1114448/000104746920000872/0001047469-20-000872-index.htm
2019-05-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919031228/0001104659-19-031228-index.htm
2019-05-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919032999/0001104659-19-032999-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919066818/0001104659-19-066818-index.htm
2019-11-25SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919067074/0001104659-19-067074-index.htm
2019-12-19SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919074076/0001104659-19-074076-index.htm
2019-12-23SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465919075309/0001104659-19-075309-index.htm
2020-01-06SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920001225/0001104659-20-001225-index.htm
2020-02-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920016892/0001104659-20-016892-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054421/0001104659-20-054421-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054428/0001104659-20-054428-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054430/0001104659-20-054430-index.htm
2020-04-30S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920054435/0001104659-20-054435-index.htm
2020-06-01SDhttps://www.sec.gov/Archives/edgar/data/1114448/000110465920068035/0001104659-20-068035-index.htm
2020-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920076964/0001104659-20-076964-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920082864/0001104659-20-082864-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920084106/0001104659-20-084106-index.htm
2020-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920095585/0001104659-20-095585-index.htm
2020-08-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1114448/000110465920096920/0001104659-20-096920-index.htm
2019-03-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001715/0001171843-19-001715-index.htm
2019-03-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319001911/0001171843-19-001911-index.htm
2019-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319002004/0001171843-19-002004-index.htm
2019-05-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003156/0001171843-19-003156-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003609/0001171843-19-003609-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003610/0001171843-19-003610-index.htm
2019-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003629/0001171843-19-003629-index.htm
2019-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319003886/0001171843-19-003886-index.htm
2019-07-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004272/0001171843-19-004272-index.htm
2019-07-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319004915/0001171843-19-004915-index.htm
2019-08-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005727/0001171843-19-005727-index.htm
2019-09-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319005958/0001171843-19-005958-index.htm
2019-09-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006182/0001171843-19-006182-index.htm
2019-10-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006290/0001171843-19-006290-index.htm
2019-10-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006403/0001171843-19-006403-index.htm
2019-10-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319006937/0001171843-19-006937-index.htm
2019-11-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007057/0001171843-19-007057-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007596/0001171843-19-007596-index.htm
2019-11-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007762/0001171843-19-007762-index.htm
2019-12-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319007956/0001171843-19-007956-index.htm
2019-12-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184319008118/0001171843-19-008118-index.htm
2020-01-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000083/0001171843-20-000083-index.htm
2020-01-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320000619/0001171843-20-000619-index.htm
2020-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001368/0001171843-20-001368-index.htm
2020-03-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001424/0001171843-20-001424-index.htm
2020-03-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320001840/0001171843-20-001840-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002076/0001171843-20-002076-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002077/0001171843-20-002077-index.htm
2020-04-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320002294/0001171843-20-002294-index.htm
2020-05-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320003608/0001171843-20-003608-index.htm
2020-06-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004387/0001171843-20-004387-index.htm
2020-06-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004563/0001171843-20-004563-index.htm
2020-07-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320004689/0001171843-20-004689-index.htm
2020-08-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320005971/0001171843-20-005971-index.htm
2020-08-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006020/0001171843-20-006020-index.htm
2020-09-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006198/0001171843-20-006198-index.htm
2020-09-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320006593/0001171843-20-006593-index.htm
2020-10-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000117184320007068/0001171843-20-007068-index.htm
2019-04-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000028/0001370368-19-000028-index.htm
2019-07-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000049/0001370368-19-000049-index.htm
2019-10-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036819000062/0001370368-19-000062-index.htm
2020-01-2920-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000003/0001370368-20-000003-index.htm
2020-01-29IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1114448/000137036820000005/0001370368-20-000005-index.htm
2020-01-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000007/0001370368-20-000007-index.htm
2020-04-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000061/0001370368-20-000061-index.htm
2020-07-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000069/0001370368-20-000069-index.htm
2020-10-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1114448/000137036820000086/0001370368-20-000086-index.htm

Novartis AG (NVS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novartis AG (NVS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: < 1%
Institutional Ownership: 1008%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-30Bioventures Ltd NovartisInsiderBuy125,000.0017.002,125,000.001,181,258.00https://www.sec.gov/Archives/edgar/data/1114448/000110465920080559/0001104659-20-080559-index.htm
2019-05-28Bioventures Ltd Novartis10% Share HolderBuy168,630.0014.002,360,820.001,769,641.00https://www.sec.gov/Archives/edgar/data/1114448/000110465919032920/0001104659-19-032920-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell20,610.001.9039,159.002,079,394.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell106,540.001.85197,099.002,100,004.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000143/0000925421-19-000143-index.htm
2019-03-15Bioventures Ltd Novartis10% Share HolderSell43,800.001.9284,096.002,206,544.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-14Bioventures Ltd Novartis10% Share HolderSell13,800.001.8825,944.002,250,344.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2019-03-13Bioventures Ltd Novartis10% Share HolderSell132,738.002.12281,404.562,264,144.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000114/0000925421-19-000114-index.htm
2020-06-19Bioventures Ltd NovartisInsiderSell1,001,312.008.258,260,824.002,467,961.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-18Bioventures Ltd NovartisInsiderSell900.009.048,136.003,469,273.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000256/0000925421-20-000256-index.htm
2020-06-17Bioventures Ltd Novartis10% Share HolderSell4,622.009.2742,845.943,470,173.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-16Bioventures Ltd Novartis10% Share HolderSell8,600.009.3079,980.003,474,795.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-15Bioventures Ltd Novartis10% Share HolderSell6,164.009.0555,784.203,483,395.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000254/0000925421-20-000254-index.htm
2020-06-12Bioventures Ltd Novartis10% Share HolderSell1,500.009.1913,785.003,489,559.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-11Bioventures Ltd Novartis10% Share HolderSell7,200.009.2166,312.003,491,059.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-10Bioventures Ltd Novartis10% Share HolderSell8,532.009.4680,712.723,498,259.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000248/0000925421-20-000248-index.htm
2020-06-09Bioventures Ltd Novartis10% Share HolderSell7,000.009.3865,660.003,506,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-08Bioventures Ltd Novartis10% Share HolderSell5,659.009.6654,665.943,513,791.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-05Bioventures Ltd Novartis10% Share HolderSell8,652.009.6683,578.323,519,450.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000244/0000925421-20-000244-index.htm
2020-06-04Bioventures Ltd Novartis10% Share HolderSell4,088.009.5539,040.403,528,102.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-03Bioventures Ltd Novartis10% Share HolderSell5,208.009.7850,934.243,532,190.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2020-06-02Bioventures Ltd Novartis10% Share HolderSell5,669.009.6854,875.923,537,398.00https://www.sec.gov/Archives/edgar/data/1114448/000092542120000228/0000925421-20-000228-index.htm
2019-11-12Bioventures Ltd Novartis10% Share HolderBuy250,000.0012.003,000,000.003,543,067.00https://www.sec.gov/Archives/edgar/data/1114448/000089924319027115/0000899243-19-027115-index.htm
2019-04-26Bioventures Ltd Novartis10% Share HolderSell138,704.001.03142,865.124,049,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-25Bioventures Ltd Novartis10% Share HolderSell563,096.001.03579,988.884,188,508.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000179/0000925421-19-000179-index.htm
2019-04-24Bioventures Ltd Novartis10% Share HolderSell16,403.001.0316,895.094,751,604.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-23Bioventures Ltd Novartis10% Share HolderSell27,554.001.0328,380.624,768,007.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-22Bioventures Ltd Novartis10% Share HolderSell7,100.000.976,887.004,795,561.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000157/0000925421-19-000157-index.htm
2019-04-15Bioventures Ltd Novartis10% Share HolderSell28,794.000.9928,506.064,802,661.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-12Bioventures Ltd Novartis10% Share HolderSell30,908.001.0432,144.324,831,455.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-11Bioventures Ltd Novartis10% Share HolderSell57,438.001.0862,033.044,862,363.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000153/0000925421-19-000153-index.htm
2019-04-10Bioventures Ltd Novartis10% Share HolderSell140,230.001.09152,850.704,919,801.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-09Bioventures Ltd Novartis10% Share HolderSell32,991.001.0133,320.915,060,031.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-08Bioventures Ltd Novartis10% Share HolderSell27,525.001.0228,075.505,093,022.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000149/0000925421-19-000149-index.htm
2019-04-05Bioventures Ltd Novartis10% Share HolderSell24,661.001.0225,154.225,120,547.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-04Bioventures Ltd Novartis10% Share HolderSell47,900.001.0148,379.005,145,208.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-03Bioventures Ltd Novartis10% Share HolderSell58,033.000.9655,711.685,193,108.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000145/0000925421-19-000145-index.htm
2019-04-02Bioventures Ltd Novartis10% Share HolderSell51,754.000.9750,201.385,251,141.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-04-01Bioventures Ltd Novartis10% Share HolderSell116,909.000.95111,063.555,302,895.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-29Bioventures Ltd Novartis10% Share HolderSell63,100.000.9157,421.005,419,804.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000141/0000925421-19-000141-index.htm
2019-03-28Bioventures Ltd Novartis10% Share HolderSell88,835.000.9483,504.905,482,904.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-27Bioventures Ltd Novartis10% Share HolderSell50,749.000.9950,241.515,571,739.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm
2019-03-26Bioventures Ltd Novartis10% Share HolderSell177,762.001.01179,539.625,622,488.00https://www.sec.gov/Archives/edgar/data/1114448/000092542119000139/0000925421-19-000139-index.htm